Similarly, small-molecule inhibitors of RNR, including gemcitabine and hydroxyurea, upregulate expression of c-Jun and c-Fos and downregulate c-Myc in Ewing sarcoma cells. The gene discussed is FOS; the disease is Ewing sarcoma.